ResMed revenue and financials

RMD · NYSE · USD

$222.86+1.81%+$3.97

Close · October 5, 2026

In the fiscal year ended June 2026, ResMed reported revenue of $5.65B (+9.85% year over year). Net income was $1.52B, a net margin of 26.9%.

Annual revenue · 2026: $5.65B

Fiscal year ending in June. Sources and method on the page Methodology and sources.

At a glance

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item	FY to Jun 2026	FY to Jun 2025	FY to Jun 2024	FY to Jun 2023	FY to Jun 2022	FY to Jun 2021	FY to Jun 2020	FY to Jun 2019	FY to Jun 2018	FY to Jun 2017
Total revenue	5,653	5,146	4,685	4,223	3,578	3,197	2,957	2,607	2,340	2,067
Cost of revenue	2,202	2,091	2,030	1,867	1,554	1,358	1,239	1,113	1,005	865
Gross profit	3,452	3,055	2,655	2,356	2,024	1,839	1,718	1,494	1,335	1,202
Selling, general and administrative	1,108	991	917	874	738	—	—	—	—	—
Research and development	378	331	308	288	254	225	202	181	155	144
Operating income	1,887	1,685	1,320	1,132	1,000	904	810	579	542	426
EBIT	1,920	1,687	1,384	1,152	1,002	—	—	—	—	—
EBITDA	2,096	1,860	1,534	1,292	1,126	—	—	—	—	—
Interest expense	—	0.6	49.7	51.1	22.3	24.0	40.4	36.2	28.4	28.2
Pre-tax income	1,919	1,678	1,265	1,102	960	—	—	—	—	—
Income tax	396	277	244	204	181	409	111	114	206	76.5
Net income	1,523	1,401	1,021	898	779	475	622	405	316	342
Net income to common shareholders	1,523	1,401	1,021	898	779	—	—	—	—	—
Basic EPS	10.47	9.55	6.94	6.12	5.34	3.27	4.31	2.83	2.21	2.42
Diluted EPS	10.43	9.51	6.92	6.09	5.30	3.24	4.27	2.80	2.19	2.40
Average shares (basic)	146	147	147	147	146	—	—	—	—	—
Average shares (diluted)	146	147	148	147	147	146	146	144	144	142
Dividend per share	2.40	2.12	1.92	1.76	1.68	—	—	—	—	—